Group One Trading, L.P. Aclaris Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.01 - $1.36 $129,564 - $174,463	-128,282 Reduced 95.85%	5,549 $6,000
Q1 2024 May 10, 2024	BUY	$0.92 - $1.44 $52,099 - $81,547	56,630 Added 73.35%	133,831 $165,000
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $5,703 - $57,832	8,911 Added 13.05%	77,201 $81,000
Q3 2023 Nov 09, 2023	BUY	$6.56 - $10.95 $119,779 - $199,936	18,259 Added 36.5%	68,290 $467,000
Q2 2023 Aug 09, 2023	SELL	$7.89 - $10.64 $326,606 - $440,442	-41,395 Reduced 45.28%	50,031 $518,000
Q1 2023 May 12, 2023	BUY	$7.07 - $17.95 $646,381 - $1.64 Million	91,426 New	91,426 $739,000
Q3 2022 Nov 09, 2022	SELL	$13.07 - $18.22 $26,126 - $36,421	-1,999 Reduced 81.39%	457 $7,000
Q2 2022 Aug 11, 2022	SELL	$10.16 - $17.08 $2,600 - $4,372	-256 Reduced 9.44%	2,456 $34,000
Q1 2022 May 12, 2022	SELL	$9.74 - $17.92 $6,886 - $12,669	-707 Reduced 20.68%	2,712 $47,000
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $32,184 - $48,499	-2,623 Reduced 43.41%	3,419 $50,000
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $57,172 - $80,332	4,273 Added 241.55%	6,042 $109,000
Q2 2021 Aug 10, 2021	SELL	$17.08 - $29.6 $245,610 - $425,648	-14,380 Reduced 89.05%	1,769 $31,000
Q1 2021 May 12, 2021	SELL	$5.86 - $27.73 $184,496 - $873,051	-31,484 Reduced 66.1%	16,149 $407,000
Q4 2020 Feb 10, 2021	BUY	$2.65 - $7.61 $106,087 - $304,651	40,033 Added 526.75%	47,633 $308,000
Q3 2020 Nov 12, 2020	BUY	$1.5 - $2.71 $7,650 - $13,821	5,100 Added 204.0%	7,600 $20,000
Q2 2020 Aug 13, 2020	BUY	$1.04 - $1.73 $2,600 - $4,325	2,500 New	2,500 $4,000
Q1 2020 May 13, 2020	SELL	$0.75 - $2.18 $8,588 - $24,963	-11,451 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$1.02 - $1.97 $9,133 - $17,639	8,954 Added 358.59%	11,451 $22,000
Q3 2019 Nov 12, 2019	SELL	$0.79 - $2.47 $12,707 - $39,729	-16,085 Reduced 86.56%	2,497 $3,000
Q2 2019 Aug 09, 2019	BUY	$2.13 - $7.06 $37,769 - $125,187	17,732 Added 2086.12%	18,582 $41,000
Q1 2019 May 13, 2019	BUY	$5.63 - $7.84 $4,785 - $6,664	850 New	850 $5,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.2 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.8 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.8 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.4 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account